United Therapeutics CEO Martine A. Rothblatt disposes of 9,500 shares worth USD 4.76 million

PUBT · 1d ago
United Therapeutics CEO Martine A. Rothblatt disposes of 9,500 shares worth USD 4.76 million
  • United Therapeutics Chairperson and CEO Martine A. Rothblatt exercised stock options for 9,500 shares at $117.76 on Sept. 15.
  • The same trust sold 9,500 shares in multiple trades at weighted-average prices from $499.77 to $504.57 on Sept. 15.
  • Trust holdings ended at 324,443 shares of common stock.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. United Therapeutics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001106578-26-000142), on September 16, 2026, and is solely responsible for the information contained therein.